Tag archive for ‘Cryoport potential benefits from COVID-19 vaccines’
Cryoport: Potential Commercial Benefits from COVID-19 Vaccines (CYRX, Buy, $46.43)
The market has been manic depressive on assessing the potential commercial benefit of COVID-19 vaccines to Cryoport. The stock ran up to over $60 on the mistaken premise that Pfizer would use Cryoport cryogenics shipping and logistics to support shipments of its vaccine. This premise was wrong because the Pfizer vaccine is shipped at minus […]